Author:
Zhang Yuyuan,Guo Manman,Wang Libo,Weng Siyuan,Xu Hui,Ren Yuqing,Liu Long,Guo Chunguang,Cheng Quan,Luo Peng,Zhang Jian,Han Xinwei
Funder
Major Science and Technology Project of Hainan Province
Reference42 articles.
1. Exosomal plasma gelsolin is an immunosuppressive mediator in the ovarian tumor microenvironment and a determinant of chemoresistance;Onuma;Cells.,2022
2. Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant;Yang;Front. Immunol.,2020
3. Ovarian cancer immunotherapy and personalized medicine;Morand;Int. J. Mol. Sci.,2021
4. Immunotherapy for ovarian cancer: what’s next?;Kandalaft;J. Clin. Oncol.,2011
5. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer;Konstantinopoulos;Cancer Discov.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献